# OnCo record st-01156 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/st-01156/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "st-01156" ;
  schema:name "ST-01156"@en ;
  schema:description "ST-01156 is an experimental oral small-molecule molecular glue degrader from SEED Therapeutics, in phase 1 trials for ewing sarcoma, hepatocellular carcinoma and biliary tract cancer and other cancers."@en ;
  schema:url <https://onco.cc/drugs/st-01156/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://seedtherapeutics.com/pipeline>, <https://seedtherapeutics.com/pipeline>, <https://seedtherapeutics.com/>, <https://clinicaltrials.gov/api/v2/studies/NCT07197554>, <https://clinicaltrials.gov/search?intr=ST-01156> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Oral small-molecule molecular glue degrader" ;
  onco:cancers <https://onco.cc/cancers/ewing-sarcoma/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/biliary-tract-cancer/>, <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/rbm39/> ;
  onco:companies <https://onco.cc/companies/seed-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07197554/> .